R L Dunn

Author PubWeight™ 68.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000 6.42
2 Spectra of spontaneous mutations in Escherichia coli strains defective in mismatch correction: the nature of in vivo DNA replication errors. Proc Natl Acad Sci U S A 1987 4.35
3 Spontaneous mutation in the Escherichia coli lacI gene. Genetics 1991 2.53
4 A return on investment evaluation of the Citibank, N.A., health management program. Am J Health Promot 1999 2.20
5 Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol 2001 1.95
6 Escherichia coli mutT mutator effect during in vitro DNA synthesis. Enhanced A.G replicational errors. J Biol Chem 1987 1.68
7 Mutants of Escherichia coli with increased fidelity of DNA replication. Genetics 1993 1.66
8 Genetic requirements and mutational specificity of the Escherichia coli SOS mutator activity. J Bacteriol 1997 1.64
9 The relationship between modifiable health risks and group-level health care expenditures. Health Enhancement Research Organization (HERO) Research Committee. Am J Health Promot 2000 1.63
10 The C-C (6-4) UV photoproduct is mutagenic in Escherichia coli. Proc Natl Acad Sci U S A 1986 1.61
11 Mechanisms of ultraviolet-induced mutation. Mutational spectra in the Escherichia coli lacI gene for a wild-type and an excision-repair-deficient strain. J Mol Biol 1987 1.57
12 The role of psychologists in the treatment, management, and prevention of chronic mental illness. Am Psychol 1993 1.52
13 The relationship between modifiable health risks and health care expenditures. An analysis of the multi-employer HERO health risk and cost database. J Occup Environ Med 1998 1.50
14 An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci U S A 2003 1.33
15 Transcription-repair coupling determines the strandedness of ultraviolet mutagenesis in Escherichia coli. Proc Natl Acad Sci U S A 1992 1.31
16 Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy. Int J Radiat Oncol Biol Phys 2000 1.26
17 Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer. J Clin Oncol 1998 1.22
18 Prospective assessment of patient reported urinary continence after radical prostatectomy. J Urol 2000 1.18
19 Hypersensitivity of Escherichia coli Delta(uvrB-bio) mutants to 6-hydroxylaminopurine and other base analogs is due to a defect in molybdenum cofactor biosynthesis. J Bacteriol 2000 1.14
20 Controlling for systematic selection in retrospective analyses: an application to fluoxetine and sertraline prescribing in the United Kingdom. Value Health 2006 1.09
21 Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease. Clin Cancer Res 2000 1.09
22 Assessment of early continence recovery after radical prostatectomy: patient reported symptoms and impairment. J Urol 2001 1.06
23 Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys. J Biomed Mater Res 1999 1.04
24 Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets. J Periodontol 1983 1.03
25 Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant. AAPS PharmSciTech 2000 1.02
26 Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate. J Pharm Sci 2000 1.01
27 Psychosocial characteristics of individuals with non-stage IV melanoma. J Clin Oncol 2001 0.98
28 Growth factors regulate expression of osteoblast-associated genes. J Periodontol 1999 0.98
29 Effects of GnRH agonist (leuprolide) on reproduction and behaviour in female wapiti (Cervus elaphus nelsoni). Reprod Suppl 2002 0.97
30 Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide. Int J Pharm 2000 0.97
31 X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer model. Cell Death Differ 2008 0.97
32 Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease. Urology 2005 0.94
33 A two-step intervention of increase mammography among women aged 65 and older. Am J Public Health 1997 0.92
34 Periodontal pocket treatment in beagle dogs using subgingival doxycycline from a biodegradable system. I. Initial clinical responses. J Periodontol 1996 0.86
35 The drug delivery and biomaterial attributes of the ATRIGEL technology in the treatment of periodontal disease. Expert Opin Investig Drugs 1998 0.85
36 Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells. J Natl Cancer Inst 2000 0.85
37 Periodontal regeneration in naturally occurring Class II furcation defects in beagle dogs after guided tissue regeneration with bioabsorbable barriers. J Periodontol 1997 0.84
38 Initial study of guided tissue regeneration in Class II furcation defects after use of a biodegradable barrier. Int J Periodontics Restorative Dent 1995 0.80
39 Projecting future medical care costs using four scenarios of lifestyle risk rates. Am J Health Promot 2000 0.80
40 Effect of Escherichia coli dnaE antimutator mutants on mutagenesis by the base analog N4-aminocytidine. Mutat Res 1998 0.80
41 Gender-specific effects of modifiable health risk factors on coronary heart disease and related expenditures. HERO Research Committee. Health Enhancement Research Organization. J Occup Environ Med 2000 0.79
42 Improving postoperative MR imaging of pituitary macroadenomas: comparison of full and reduced dose of gadopentetate dimeglumine. Eur Radiol 2000 0.79
43 Preliminary in vivo studies on the osteogenic potential of bone morphogenetic proteins delivered from an absorbable puttylike polymer matrix. J Biomed Mater Res 2000 0.79
44 Apparent interaction of dimethyl sulfoxide with cisplatin released from polymer delivery devices injected subcutaneously in dogs. J Drug Target 1998 0.79
45 Biodegradation and biocompatibility of a guided tissue regeneration barrier membrane formed from a liquid polymer material. J Biomed Mater Res 1998 0.79
46 Sister-chromatid exchange analyses in rodent maternal, embryonic and extra-embryonic tissues: transplacental and direct mutagen exposures. Mutat Res 1981 0.78
47 Delivery of proteins from a controlled release injectable implant. Pharm Biotechnol 1997 0.78
48 Altered monocyte CD44 expression in peripheral arterial disease is corrected by fish oil supplementation. Nutr Metab Cardiovasc Dis 2008 0.77
49 The use of prostacyclin analogue-containing suture for the prevention of postoperative venous thrombosis in the rat. Plast Reconstr Surg 1986 0.77
50 Whole mouth microbiota effects following subgingival delivery of sanguinarium. J Periodontol 1995 0.77
51 Differences between descriptive and multivariate estimates of the impact of Chevron Corporation's Health Quest Program on medical expenditures. J Occup Environ Med 1998 0.77
52 Healing patterns associated with an Atrisorb barrier in guided tissue regeneration. Compendium 1993 0.77
53 Introduction and expression of an insect proteinase inhibitor in alfalfa Medicago sativa L. Plant Cell Rep 1994 0.76
54 Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive. Biol Reprod 1983 0.75
55 Rescoring the NIH chronic prostatitis symptom index: nothing new. Prostate Cancer Prostatic Dis 2009 0.75
56 Periodontal healing after guided tissue regeneration with Atrisorb barriers in beagle dogs. Int J Periodontics Restorative Dent 1995 0.75
57 A team approach to psychotherapy in family practice. Can Fam Physician 1979 0.75
58 Analysis of a managed psychiatric disability program. J Occup Environ Med 2001 0.75
59 Fluoxetine and dothiepin therapy in primary care and health resource utilization: Evidence from the United Kingdom. Int J Psychiatry Clin Pract 1999 0.75
60 Gaps in antidepressant prescribing in primary care in the United Kingdom. Int Clin Psychopharmacol 1998 0.75
61 The antimutator phenotype of E. coli mud is only apparent and results from delayed appearance of mutants. Mutat Res 2001 0.75